Free Coronavirus Wellbeing Support Service

A new 24/7 support service specifically designed to help people through the COVID-19 pandemic is now available free of charge to all Australians.   The Coronavirus Mental Wellbeing Support Service has been developed by Beyond Blue to address the growing mental health impact of the pandemic, including fear about the virus, financial stress, family stress,…

Details

$1.5 million to support clinical management of COVID-19

The Australian Government is investing $1.5 million to support guidance for clinicians to ensure they are given the best possible advice on managing COVID-19 patients. The National COVID-19 Clinical Evidence Taskforce will receive $1.5 million from the Medical Research Future Fund (MRFF) to deliver ‘living guidelines’ on the clinical management of patients with suspected or…

Details

Training more nurses for critical care

The Australian Government will fund up to 20,000 new online education places to enable Registered Nurses (RNs) to develop knowledge enabling them to assist in the delivery of care in intensive care and high dependency units across Australia.   The online training will allow experienced RNs to be used to maximum effect in the national…

Details

Funding Delivered for Western Port Biosphere

The Morrison Government is delivering $300,000 to help protect the exceptional biodiversity of Australia’s Mornington Peninsula and the Western Port Biosphere.   The Biosphere holds a uniquely wide range of habitat types and mix of environmental landscapes, including National and Marine Parks. This diversity made it a significant environmental area, identified as a Biosphere Reserve…

Details

Breakthrough medicines now available for blood cancer, breast cancer, HIV and epilepsy, saving patients up to $194, 000

There’s new hope today for thousands of Australian patients with myeloma, breast cancer, HIV and epilepsy, with the Morrison Government expanding the listing of four key medicines on the Pharmaceutical Benefits Scheme (PBS).   From 1 April, Revlimid® (lenalidomide) will be available to patients receiving maintenance treatment for newly diagnosed multiple myeloma, who have already…

Details